CVOT Summit Report 2025: advances along the cardiovascular–kidney–metabolic disease continuum

Abstract The 11th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 20–21, 2025. The Summit provided a multidisciplinary forum to review and discuss recent outcome trials investigating emerging pharmacological therap...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Oliver Schnell, Arnav Agarwal, Michel Azizi, Dennis Ballwieser, Katharine Barnard-Kelly, Tadej Battelino, Matthias Blüher, Elisabetta Bugianesi, Ana Cebrian, Antonio Ceriello, Pratik Choudhary, Thomas Danne, Colin M. Dayan, Stefano Del Prato, Robert H. Eckel, Paola Fioretto, Timothy Garvey, Jennifer B. Green, Hiddo J. L. Heerspink, Rury R. Holman, Baruch Itzhak, Stephan Jacob, Pardeep S. Jhund, Linong Ji, Parminder K. Judge, Kamlesh Khunti, Marko Korenjak, Andrew J. Krentz, Ekaterini Lambrinou, Peter Libby, Julia K. Mader, Johannes F. E. Mann, Nikolaus Marx, Chantal Mathieu, John J. V. McMurray, Dirk Müller-Wieland, Nikolaos Papanas, Dipesh C. Patel, Andreas F. H. Pfeiffer, Susanne Reger-Tan, Helena W. Rodbard, Giuseppe M. C. Rosano, Banshi Saboo, Naoki Sato, Scott D. Solomon, Eberhard Standl, Frank Tacke, Pinar Topsever, Christoph Wanner, Sean Wharton, Veronika Young
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2026-05-01
סדרה:	Cardiovascular Diabetology
נושאים:	Diabetes CGM Heart failure MASLD Obesity SGLT2 inhibitor
גישה מקוונת:	https://doi.org/10.1186/s12933-026-03140-0
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!